Chin Augmentation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure (Surgical, Non-Surgical), By End-use (Cosmetic Surgery Center, Hospitals, MedSpas), By Region & Competition, 2021-2031F

The global chin augmentation market is projected to expand significantly, rising from USD 1.71 billion in 2025 to USD 2.52 billion by 2031, at a compound annual growth rate (CAGR) of 6.68%. This surgical procedure, known clinically as mentoplasty, involves reshaping or enhancing the chin through implants or bone advancement to improve overall facial balance. Its growth is primarily fueled by consumers' increasing focus on facial symmetry and the growing acceptance of aesthetic interventions, particularly among men seeking to define their jawlines.According to data from the American Society of Plastic Surgeons, 5,529 chin augmentation procedures were performed by its member surgeons in 2024, indicating consistent demand for this specific facial contouring surgery. However, despite this steady interest, the market faces notable hurdles due to the high cost of the procedure and potential risks of surgical complications, factors that can deter both price-sensitive and risk-averse patients from pursuing treatment.

Market Driver

A primary catalyst propelling the market is the escalating demand for minimally invasive and non-surgical dermal fillers. Patients are increasingly opting for these procedures due to reduced downtime and lower risks compared to surgical mentoplasty. This shift is marked by the prevalent use of hyaluronic acid and calcium hydroxylapatite fillers, which provide a reversible and adaptable option for chin projection and contouring, thereby significantly expanding the market beyond traditional surgical candidates. This trend is evidenced by global procedure volumes, with the International Society of Aesthetic Plastic Surgery (ISAPS) reporting a 5.2% increase in hyaluronic acid procedures worldwide, totaling approximately 6.3 million treatments by June 2025, highlighting the dominance of injectable solutions in facial profiling.Simultaneously, the market is being driven by the rising adoption of jawline contouring among men, spurred by evolving aesthetic ideals that associate a defined, strong jawline with fitness and executive presence. Men are becoming a crucial consumer segment, actively seeking enhancements to improve facial structural balance and correct weak profiles, with less stigma now attached to cosmetic interventions. This demographic shift is underscored by industry data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), which indicated in its February 2025 '2024 Annual Trends Survey' that 92% of surveyed surgeons treated male patients, reflecting a broadening patient base. Furthermore, Galderma's 2025 report showing full-year 2024 Injectable Aesthetics net sales of USD 2,299 million demonstrates the financial scale supporting these procedures.

Market Challenge

The significant cost of chin augmentation presents a substantial economic barrier, hindering broader market expansion. As mentoplasty is typically categorized as an elective cosmetic procedure, it is generally not covered by medical insurance, requiring patients to bear the full financial burden themselves. This pricing structure inherently limits the accessible market primarily to high-income individuals, effectively excluding a considerable portion of the population, both male and female, who prioritize facial symmetry but lack the disposable income for such discretionary expenses. Consequently, these substantial costs frequently deter potential clients who might otherwise be motivated by the aesthetic benefits.Recent industry data corroborates this financial challenge by highlighting the steep baseline expenses involved. The American Society of Plastic Surgeons reported that in 2024, the average surgeon fee for chin augmentation was $3,641. It is critical to note that this figure solely covers the physician's charge and does not include additional essential costs such as facility fees, anesthesia, and medical tests, which can considerably elevate the final price. This cumulative financial weight directly impedes the global growth of procedure volumes, preventing the market from realizing its full potential among price-sensitive consumers.

Market Trends

The emergence of custom 3D-printed chin implants is significantly innovating the market by overcoming the limitations of conventional prosthetic shapes. Surgeons are increasingly employing computer-aided design (CAD) to create patient-specific implants (PSIs) that precisely match the individual's bony anatomy, ensuring superior contour adaptation and minimizing the risk of implant migration. This technological advancement enables accurate correction of asymmetry and microgenia without the extensive intraoperative shaping typically required for traditional porous polyethylene or silicone blocks. The commercial viability of this personalized approach is evident in the financial growth of key technology providers; Materialise reported a 14.8% increase in revenue from its Medical segment for the full year 2024, as per its February 2025 'Fourth Quarter and Full Year 2024 Results', highlighting the surging demand for personalized surgical solutions and 3D-printed medical devices.Concurrently, there is a notable shift towards autologous fat grafting, reshaping procedural preferences as patients seek natural, biocompatible alternatives to synthetic materials. This technique involves harvesting adipose tissue from the patient's own body to augment the chin and jawline, offering the dual advantages of donor site contouring and eliminating the risks of foreign body rejection associated with alloplastic implants. This trend is further amplified by the widespread use of GLP-1 weight-loss medications, which often lead to facial volume loss, prompting individuals to seek restorative options that utilize their own biology to regain structural definition. Recent clinical data from the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) substantiates this changing consumer preference, with their February 2025 '2024 Annual Trends Survey' reporting a 50% rise in the average number of fat grafting procedures performed by facial plastic surgeons over the preceding year.

Key Market Players

• New York Plastic Surgical Group
• Westlake Dermatology & Cosmetic Surgery
• Nazarian Plastic Surgery Inc.
• Ruby Surgery & Aesthetics
• Cadogan Clinics Limited
• UK Aesthetic Limited
• UK Healthcare Aesthetics Center
• Marroquin & Sandoval Plastic Surgery
• Advanced Cosmetic Surgery Limited
• Orange County Facial Plastic Surgery

Report Scope

In this report, the Global Chin Augmentation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chin Augmentation Market, By Procedure

• Surgical
• Non-Surgical

Chin Augmentation Market, By End-use

• Cosmetic Surgery Center
• Hospitals
• MedSpas

Chin Augmentation Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chin Augmentation Market.

Available Customizations:

Global Chin Augmentation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).